Medication-overuse headache and personality: A controlled study by means of the MMPI-2: Research submission

Headache

Volumn 50, Issue 2, 2010, Pages 198-209

  Sances, Grazia ^a   Galli, Federica ^a,b   Anastasi, Serena ^c   Ghiotto, Natascia ^a,d   De Giorgio, Giuseppina ^c   Guidetti, Vincenzo ^b   Firenze, Caterina ^c   Pazzi, Stefania ^a   Quartesan, Roberto ^c   Gallucci, Marcello ^e   Nappi, Giuseppe ^b,d  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d University Italy   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Assessment; Dependence; Medication overuse headache; MMPI 2; Personality

Indexed keywords

ANALGESIC AGENT; ANTIMIGRAINE AGENT; ERGOTAMINE; OPIATE; TRIPTAN DERIVATIVE;

ADDICTION; ADDICTION ADMISSION SCALE; ADDICTION POTENTIAL SCALE; ADULT; ANALGESIC AGENT ABUSE; ARTICLE; CHRONIC DAILY HEADACHE; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; DRUG INDUCED HEADACHE; EGO STRENGTH; EMOTIONAL STRESS; FEMALE; HEADACHE; HUMAN; HYPOCHONDRIASIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; MULTIPLE DRUG ABUSE; PARANOIA; PERSONALITY; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; QUESTIONNAIRE; SCHIZOPHRENIA; TENSION HEADACHE;

ADULT; COMORBIDITY; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; HYPOCHONDRIASIS; MALE; MENTAL DISORDERS; MIDDLE AGED; MMPI; NEUROTIC DISORDERS; PERSONALITY; PERSONALITY ASSESSMENT; PREDICTIVE VALUE OF TESTS; PREVALENCE; SUBSTANCE-RELATED DISORDERS; TENSION-TYPE HEADACHE;

EID: 75849155485     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01593.x     Document Type: Article

References (55)

1. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999 39: 190 196.
2. Pascual J, Colás R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep. 2001 5: 529 536.
3. Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse among subjects with headache, neck, and low-back pain. Neurology. 2004 62: 1540 1544.
4. Katsarava Z, Jensen R. Medication-overuse headache: Where are we now? Curr Opin Neurology. 2007 20: 326 330.
5. Rapoport A, Stang P, Gutterman DL, et al. Analgesic rebound headache in clinical practice: Data from a physician survey. Headache. 1996 36: 14 19.
6. Radat F, Irachabal S, Swendsen J, Henry P. Analgesic abuse and psychiatric comorbidity in headache patients. Encephale. 2002 28 (5 Pt 1 466 471.
7. Headache Classification Committee, Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 26: 742 746.
8. Guidetti V, Galli F. Psychiatric comorbidity in chronic daily headache: Pathophysiology, etiology, and diagnosis. Curr Pain Headache Rep. 2002 6: 492 497.
9. Guidetti V, Galli F, Fabrizi P, et al. Headache and psychiatric comorbidity: Clinical aspects and outcome in an 8-year follow-up study. Cephalalgia. 1998 18: 455 462.
10. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache. 1987 27: 102 106.
11. Radat F, Sakh D, Lutz G, El Amrani M, Ferreri M, Bousser MG. Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache. 1999 39: 477 480.
12. Bigal ME, Sheftell FD, Rapaport AM, Tepper SJ, Weeks R, Baskin SM. MMPI personality profiles in patients with primary chronic headache: A case-control study. Neurol Sci. 2003 24.
13. Atasoy HT, Atasoy N, Unal AE, Emre U, Sumer M. Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain. 2005 9: 285 291.
14. Angst J, Merikangas KR. Headache and personality. Clin Neuropharmacol. 1992 15 (Suppl. Pt A 273A 274A.
15. Merikangas KR, Stevens DE, Angst J. Headache and personality: Results of a community sample of young adults. J Psychiatr Res. 1993 27: 187 196.
16. Silberstein SD, Lipton RB, Breslau N. Migraine: Association with personality characteristics and psychopathology. Cephalalgia. 1995 15: 358 369.
17. Mongini F, Defilippi N, Negro C. Chronic daily headache. A clinical and psychological profile before and after the treatment. Headache. 1997 37: 83 87.
18. Mongini F, Keller R, Deregibus A, Raviola F, Mongini T, Sancarlo M. Personality traits, depression and migraine in women: A longitudinal study. Cephalalgia. 2003 23: 186 192.
19. Huber D, Henrich G. Personality traits and stress sensivity in migraine patients. Behav Med. 2003 29: 4 13.
20. Mongini F, Rota E, Deregibus A, Mura F, Francia Germani A, Mongini T. A comparative analysis of personality profile and muscle tenderness between chronic migraine and chronic tension-type headache. Neurol Sci. 2005 26: 203 207.
21. Luconi R, Bartolini M, Taffi R, et al. Prognostic significante of personality profiles in patients with chronic migraine. Headache. 2007 47: 1118 1124.
22. Lovati C, D'Amico D, Brambilla A, Mariani C, Bussone G. Personality profile and allodynic migraine. Neurol Sci. 2008 29 (Suppl. 1 S152 S154.
23. Saper JR, Hamel RL, Lake AE 3rd. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia. 2005 25: 545 546.
24. Radat F, Creac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005 25: 519 522.
25. Fuh JL, Wang SJ, Lu SR, Juang KD. Does medication overuse headache represent a behavior of dependence? Pain. 2005 119: 49 55.
26. Radat F, Creac'h C, Guegan-Massardier E, et al. Behavioral dependence in patients with medication overuse headache: A cross-sectional study in consulting patients using the DSM-IV criteria. Headache. 2008 48: 1026 1036.
27. Kudrow L, Sutkus BJ. MMPI pattern specificity in primary headache disorders. Headache. 1979 19: 18 24.
28. Ellertsen B, Kløve H. MMPI patterns in chronic muscle pain, tension headache, and migraine. Cephalalgia. 1987 7: 65 71.
29. Ellertsen B, Troland K, Kløve H. MMPI profiles in migraine before and after biofeedback treatment. Minnesota Multiphasic Personality Inventory. Cephalalgia. 1987 7: 101 108.
30. Mongini F, Ferla E, Maccagnani C. MMPI profiles in patients with headache or craniofacial pain: A comparative study. Cephalalgia. 1992 12: 91 98.
31. Mongini F, Ibertis F, Barbalonga E, Raviola F. MMPI-2 profiles in chronic daily headache and their relationship to anxiety levels and accompanying symptoms. Headache. 2000 40: 466 472.
32. Mongini F, Deregibus A, Rota E. Psychiatric disorders and muscle tenderness in episodic and chronic migraine. Expert Rev Neurother. 2005 5: 635 642.
33. Weed NC, Butcher JN, McKenna T, Ben-Porath YS. New measures for assessing alcohol and drug abuse with the MMPI-2: The APS and AAS. J Pers Assess. 1992 58: 389 404.
34. Greene RL, Weed NC, Butcher JN, Arredondo R, Davis HG. A cross-validation of MMPI-2 substance abuse scales. J Pers Assess. 1992 58: 405 410.
35. Weybrew BB. MMPI patterns of physically and psychologically dependent drug abusers. Percept Mot Skills. 1996 83: 640 642.
36. Ladd JS. MMPI-2 critical item norms in chemically dependent inpatients. J Clin Psychol. 1996 52: 367 372.
37. Clements R, Heintz JM. Diagnostic accuracy and factor structure of the AAS and APS scales of the MMPI-2. J Pers Assess. 2002 79: 564 582.
38. Headache Classification. Subcommittee of the International Headache Society. The International classification of headache disorders II Ed. Cephalalgia. 2004 24 (Suppl. 1 9 160.
39. Silberstein SD, Olesen J, Bousser M-G, et al. The International Classification of Headache Disorders, 2nd edition (ICHD-II)-revision of criteria for Medication-overuse headache. Cephalalgia. 2005 25: 460 465.
40. Ghiotto N, Sances G, Galli F, et al. Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol). Cephalalgia. 2009 29: 233 243.
41. Sances G, Ghiotto N, Galli F, Guaschino E, Rezzani C, Nappi G. Risk factors in medication overuse headache: A one-year follow-up study. Cephalalgia. 2009 in press.
42. Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B. The Minnesota Multiphasic Personality Inventory-2 (MMPI-2): Manual for Administration and Scoring. Minneapolis, MN: University of Minnesota Press 1989.
43. Ferrari A, Cicero AF, Bertolini A, Leone S, Pasciullo G, Sternieri E. Need for analgesics/drugs of abuse: A comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalalgia. 2006 26: 187 193.
44. Cowan DT, Allan LG, Libretto SE, Griffiths P. Opioid drugs: A comparative survey of therapeutic and "street" use. Pain Med. 2001 2: 193 203.
45. Elander J, Lusher J, Bevan D, Telfer P, Burton B. Understanding the causes of problematic pain management in sickle cell disease: Evidence that pseudoaddiction plays a more important role that genuine analgesic dependence. J Pain Symptom Manage. 2004 27: 156 169.
46. Weissman DE, Haddox JD. Opioid pseudoaddiction-An iatrogenic syndrome. Pain. 1989 36: 363 366.
47. Ferrari A, Stefani M, Sternieri S, Bertolotti M, Sternieri E. Analgesic drug taking: Beliefs and behaviour among headache patients. Headache. 1997 37: 88 94.
48. Michultka DM, Blanchard EB, Appelbaum KA, Jaccard J, Dentinger MP. The refractory headache patient-II. High medication consumption (analgesic rebound) headache. Behav Res Ther. 1989 27: 411 420.
49. Koob GF, Caine SB, Parsons L, Markou A, Weiss F. Opponent process model and psychostimulant addiction. Pharmacol Biochem Behav. 1997 57: 513 521.
50. Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006 129: 543 550.
51. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002 59: 1011 1014.
52. Sbrana A, Bizzarri JV, Rucci P, et al. The spectrum of substance use in mood and anxiety disorders. Compr Psychiatry. 2005 46: 6 13.
53. Katsarava Z, Jensen R. Medication-overuse headache: Where are we now? Curr Opin Neurol. 2007 20: 326 330.
54. Ferrari A, Coccia C, Sternieri E. Past, present, and future prospects of medication-overuse headache classification. Headache. 2008 48: 1096 1102.
55. Obermann M, Katsarava Z. Management of medication-overuse headache. Expert Rev Neurother. 2007 7: 1145 1155.